CCN1 and plasma cell myeloma: Blocking antibodies targeting β-integrins (β1, β2, β3, and β7) that are relevant in myeloma[43], as well as αvβ3, the RGD-sensitive integrin comprised in CT domain, were unable to prevent the splicing induction of CCN1 mRNA by CCN1-Fc stimulation.